Akanda Corp. (AKAN) vs BioXcel Therapeutics, Inc. (BTAIQ)

Akanda Corp. and BioXcel Therapeutics, Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. and BioXcel Therapeutics, Inc. are of similar size ($2.4M and $2.3M). Across the 8 metrics below, Akanda Corp. leads on 6 and BioXcel Therapeutics, Inc. on 2.

Valuation

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
P/E — n/m 20.14
P/S n/m 1.63 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 228.73 2.56
Earnings yield — (9,475.00%) (2.99%)
Free cash flow yield 0.00% (4,201.65%) 0.00%

Profitability

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Gross margin — 53.10% 53.94%
Operating margin — (6,054.72%) 0.00%
Net margin — (9,549.87%) 0.00%
Free cash flow margin 0.00% (6,860.38%) 0.00%
Return on equity 0.00% 63.52% (0.40%)
Return on assets 0.00% (259.62%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (14.52%) 10.01%
EPS growth (last fiscal year) (139.63%) 75.63% —
Revenue growth, 5-year CAGR 44.20% — 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Debt to equity (1.08) (0.90) 0.05
Current ratio 0.58 0.21 2.31
Net debt to EBITDA (2.75) (1.61) 0.85

Dividend

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AKAN BTAIQ Drug Manufacturers Specialty & Generic median
Market cap 2.44m 2.31m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack